IRIS
PESCE, GIAMPAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.664
Totale 8.664
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.664
Totale 8.664
Salva come PNG Salva come JPEG
Città #
Genova 6.846
Rapallo 940
Genoa 828
Vado Ligure 38
Bordighera 12
Totale 8.664
Salva come PNG Salva come JPEG
Nome #
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late phase reactions after allergen-specific challenge. 167
Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. 143
Adhesion molecules in allergy. 137
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets 128
A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid. 127
Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm. 126
Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation 125
B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. 121
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 120
Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy 120
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 118
The management of the patient with unexpected autoantibody positivity 116
Unexpected elevated free thyroid hormones in pregnancy 116
Effects of conjunctival hyperosmolar challenge in allergic subjects and normal controls. 114
THE SOLUBLE FORM OF CTLA-4 FROM SERUM OF PATIENTS WITH AUTOIMMUNE DISEASES REGULATES T-CELL RESPONSES. 113
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 113
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 113
Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test. 112
Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference 112
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury 111
Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 111
The adhesion molecules of allergic inflammation: recent insights into their functional roles. 109
SERUM LAIR-2 IS INCREASED IN AUTOIMMUNE THYROID DISEASES 109
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 109
Intercellular adhesion molecule-1 on cultured human epithelial cell lines: influence of proinflammatory cytokines 108
The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes. 107
Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection 107
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. 106
Co-stimulatory molecules in Graves' disease 105
Oversecretion of soluble CTLA-4 in various autoimmune diseases overlapping celiac disease. 105
Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: comparison between different methods. 105
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro 104
Population screening for coeliac disease in a low prevalence area in Italy 104
BT3 molecules ligation enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 103
Occurrence of overt celiac disease in the elderly following total thyroidectomy 102
High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis. 102
Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease 102
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 101
Tocilizumab in MOG-antibody spectrum disorder: a case report 101
In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation 100
Expression of very late activation antigen-1 on intrathyroid lymphocytes in autoimmune thyroid disease. 99
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 99
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update 97
Estimate of the Prevalence of Anti-Gastric Parietal Cell Autoantibodies in Healthy Individuals Is Method Dependent 97
Protective effect of loratadine on specific conjunctival provocation test. 97
Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva allergen challenge. 95
Intraepithelial gamma/delta T-cells and intestinal villous atrophy. 95
Comparison of ELISA for tissue transglutaminase autoantibodies with antiendomysium antibodies in pediatric and adult patients with celiac disease 95
The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics 95
Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation. 92
Cetirizine does not influence the immune response. 89
Protective effects of deflazacort on allergen-specific conjunctival challenge. 89
Follicular thyroid cells of autoimmune thyroiditis may coexpress [CAM1 (CD54) and its natural ligand LFA1 (CDlla/CD18) 88
Stress and autoimmune thyroid diseases 88
Pharmacokinetics of Der P 2 allergen and derived monomeric allergoid in allergic volunteers 83
«ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation» 83
Costimulatory molecules and autoimmune thyroid diseases 82
“IgA antiendomyisium antibodies in human umbilical cord sections as a screening test in relatives of patients with celiac disease” Allergy 52: 1017-21, 1997 81
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 81
Sensitization to food or inhalant allergens in pediatric patients. Clinical usefulness of first-level panel tests for specific IgE 80
Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with b7.1 costimulatory molecule-Comment 79
Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity. 79
Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis 78
Diagnostics of dysimmune peripheral neuropathies 76
A soluble form of CTLA-4 is present in serum of paediatric patients with acute lymphoblastic leukaemia. 75
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 75
Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis. 75
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury and tissue-transglutaminase antibody production. 70
“Possible pathogenetical relevance of Interleukin-1b in “destuctive” organ-specific autoimmune disease (Hashimoto’s thyroiditis)”. 69
Molecular events in allergc inflammation: experimental evidence and possible modulation. 62
«ICAM-1/ CD54 expression on conjunctival epithelium during pollen season» 62
Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. 62
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 61
A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection 60
Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects. 58
Use of an artificial neural network to predict Graves\' disease outcome within 2 years of drug withdrawal 58
Autoimmune thyroid disease: immunological model and clinical problem 56
I recettori BT3, membri della famiglia B7, aumentano la risposta proinfiammatoria dei monociti e della cellule dendritiche umane. 55
Functional involvement of LFA/ICAM1 adhesion system in the autologous mixed lymphocyte reaction Cell 55
La diagnostica delle malattie autoimmuni 54
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. 54
Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association 54
NERVE ULTRASOUND AND 3-TESLA MAGNETIC RESONANCE IMAGING FINDINGS IN NODO-PARANODOPATHIES: CORRELATION WITH CLINICAL AND NEUROPHYSIOLOGICAL EXAMINATIONS 52
Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount. 52
Molecole di adesione: struttura, funzione e ruolo fisiopatologico nelle malattie infiammatorie 51
Papillary thyroid cancer:phenotypic analysis of infiltrating T lymphocytes 50
null 50
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica 49
La forma solubile di CTLA-4 è espressa nel siero di pazienti pediatrici affetti da leucemia linfoblastica acuta. 48
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 48
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 45
Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays. 45
FISIOPATOLOGIA E BASI GENETICHE DELL'AUTOIMMUNITA' SISTEMICA 42
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 42
EPIDEMIOLOGIA DELLE MALATTIE AUTOIMMUNI ORGANO-SPECIFICHE 41
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 34
Neurological long-COVID in the outpatient clinic: Two subtypes, two courses 33
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 30
Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis 29
Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies 27
Totale 8.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.953
article - articoli 24.650
book - libri 0
conference - conferenze 502
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 801
Totale 51.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.324 0 60 104 144 194 262 369 171 243 410 270 97
2020/2021757 36 70 51 79 62 45 41 79 79 93 73 49
2021/20221.309 27 91 88 133 77 84 81 293 62 126 68 179
2022/20231.163 116 82 12 115 158 228 37 82 206 9 98 20
2023/2024627 33 84 33 90 48 108 26 35 38 8 25 99
2024/202571 53 18 0 0 0 0 0 0 0 0 0 0
Totale 8.839